About

Aliquam erat volutpat. Nunc vitae neque odio. Morbi diam lacus, lacinia et consequat nec, sagittis ac mauris. Etiam consectetur sed ipsum eget ornare. Aliquam imperdiet, massa non tincidunt faucibus, elit tortor tincidunt ante, ut semper lectus sapien vel arcu. Suspendisse in dictum metus, sit amet semper odio. Vivamus varius libero sit amet elit imperdiet finibus.

Return to Campus

The University of CIncinnati recognizes the health and safety benefits of implementing a multi-phased return to campus in advance of the start of the fall semester on August 24. Each of the four phases of this stepwise approach is underpinned by a set of essential health and safety measures. All members of our community are expected to do their part to ensure the health and safety of themselves and others.
 

View return to campus guide
Headshot of Name

Name, 

Title

Headshot of Curt Whitacre

Curt Whitacre, 

Director of Marketing and Communications

View Full Profile
Query for this

Further action is required to display this form embed and/or it accessible

The below criteria must be satisfied:

  • Affirm Accessibility must be checked AND
  • You have an iFrame in the form embed script without a title, use the 'iFrame Title' input to add one. AND
  • You are not using a valid embed type. Please see list of valid embed types.

The form embed script will not display on the live site until the issue above is resolved.

1

UC’s Hoxworth Blood Center, Bearcats team up to tackle need for...

September 6, 2024

Hoxworth Blood Center, University of Cincinnati, is joining forces with the UC Bearcats to address the urgent need for blood donations in the Greater Cincinnati area. This September, the Bearcat family is stepping up to support local patients, and you can be a part of it.

3

Cancer Center researcher studies combination therapy to improve...

September 6, 2024

The University of Cincinnati Cancer Center’s Eric Vick, MD, PhD, has been awarded a nearly $215,000 grant from the Leukemia and Lymphoma Society (LLS) and a $50,000 American Society of Clinical Oncology (ASCO) Young Investigator Award to continue research into a combination therapy treatment for acute myeloid leukemia (AML).

Load More
Debug Query for this